Moffitt logo

Clinical Trials Search

Clinical Trial 22082

Cancer Type: Gastrointestinal Tumor
Study Type: Supportive Care
NCT#: NCT05675059

Phase: N/A
Principal Investigator: Turner, Kea

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

Summary

The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are receiving chemotherapy.

Objective

Aim 1: Assess feasibility, acceptability, and usability of a 12-week nutritional support program for metastatic pancreatic cancer patients. Aim 2: Collect pilot data on patient outcomes (malnutrition, symptom burden, quality of life) at baseline, 4-, 8-, 12- and 16-weeks.

Treatments

Therapies

Medications

Inclusion Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Newly diagnosed metastatic or newly recurrent pancreatic cancer
  • Planning to initiate chemotherapy at Moffitt
  • Able to speak and read English
  • Able to provide informed consent

  • Exclusion Criteria

    Exclusion Criteria:

  • Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse)
  • Undergoing concurrent treatment for a secondary primary GI cancer
  • ECOG status of 2 or greater
  • Receipt of chemotherapy in the past 6 months for recurrent pancreatic cancer
  • Use of parenteral or enteral nutrition
  • Presence of malignant ascites

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.